Exclusive-Grok falls flat in Washington, undercutting SpaceX’s AI growth story

Reuters reports Grok has only three publicly identified federal AI use cases in the 2025 OMB inventory, versus 234 for OpenAI-based tools and 26 for Anthropic, suggesting weak adoption in the U.S. government. The article also says xAI lost a Department of Veterans Affairs bid and that enterprise usage has fallen to 2 per 1,000 users, undercutting the case for SpaceX/xAI’s $1.75 trillion IPO valuation. The news raises credibility and adoption concerns for Grok, though the direct market impact is mostly company-specific.

Analysis

The key market read-through is not about Grok as a product; it is about the gap between narrative optionality and actual distribution. In AI, enterprise and government adoption are the real validators, so weak public-sector traction increases the probability that xAI’s monetization curve is pushed out, which matters because IPO pricing is trying to discount a very steep terminal value today. That creates a second-order risk for any adjacent holder exposed to the “AI ecosystem” trade: if xAI is less credible as an enterprise platform, the market may start demanding higher proof-of-execution from every late-stage AI private asset.

For MSFT, the data are modestly supportive. If federal and regulated buyers continue to gravitate toward the safest default vendors, Microsoft’s distribution moat widens, especially where procurement risk matters more than benchmark novelty. The more interesting implication is margin mix: if Copilot remains the easiest procurement path, Microsoft can defend seat growth without needing to win the performance crown, which supports a longer-duration multiple than higher-beta AI names.

For GOOGL, the message is more mixed. Gemini appears to be gaining legitimacy in technical use cases where model quality matters, but the article also underscores that government buyers still default to incumbency and compliance, not pure model merit. That means GOOGL’s AI monetization is less about headline adoption counts and more about embedding Gemini into workflows where switching costs are high; the upside case likely shows up over months, not days.

Contrarian view: the market may be overreacting to federal usage as a proxy for enterprise relevance. Government procurement is unusually conservative and slow, so underpenetration today does not automatically imply weak consumer or SMB adoption. The more actionable signal is that xAI appears to be losing the “trust premium” phase of the adoption cycle, and once that happens, pricing power and contract conversion can stall well before usage data visibly deteriorate further.

Key Decisions for Investors

• Go long MSFT vs short a basket of higher-beta AI private proxies / recent AI IPO exposure for the next 1-3 months; thesis is that compliance-driven adoption keeps Microsoft on the critical path while speculative names face multiple compression if execution skepticism rises.
• Initiate a small tactical short in xAI-linked IPO exposure on any pre-deal enthusiasm, or fade related hype trades via put structures once pricing terms emerge; risk/reward improves if the IPO is marketed on TAM rather than revenue proof.
• Buy GOOGL on 4-8 week weakness only if AI product commentary remains positive, but hedge with out-of-the-money calls on MSFT; this expresses a view that distribution, not model quality alone, is what matters for federal and regulated enterprise wins.
• Avoid chasing broad AI basket exposure here; instead rotate into incumbents with procurement advantages (MSFT, to a lesser extent GOOGL) because the article suggests the next leg of AI monetization will be compliance-led rather than feature-led.
• Set a 60-90 day catalyst watch on federal authorization milestones and any xAI government contract updates; if approvals stall, expect second-order pressure on broader AI private-market marks.